These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 8937063)

  • 1. Lessons learnt from the multicentre randomized trials of tacrolimus in liver transplantation.
    Soin AS; Jamieson NV
    Natl Med J India; 1996; 9(5):224-6. PubMed ID: 8937063
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus (FK506): the pros and cons of its use as an immunosuppressant in pediatric liver transplantation.
    Cox KL; Freese DK
    Clin Invest Med; 1996 Oct; 19(5):389-92. PubMed ID: 8889279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcineurin inhibitors in heart transplantation.
    Crespo-Leiro MG
    Transplant Proc; 2005 Nov; 37(9):4018-20. PubMed ID: 16386614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis.
    Ye F; Ying-Bin X; Yu-Guo W; Hetzer R
    J Heart Lung Transplant; 2009 Jan; 28(1):58-66. PubMed ID: 19134532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimising immunosuppression.
    Schafer DF; Sorrell MF
    Lancet; 2002 Oct; 360(9340):1114-5. PubMed ID: 12387953
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved liver function and decreased hepatitis C viral load after tacrolimus was replaced by cyclosporine.
    Lorho R; Turlin B; de Lajarte-Thirouard AS; Camus C; Lakehal M; Compagnon P; Meunier B; Boudjema K; Messner M
    Transplant Proc; 2005; 37(6):2871-2. PubMed ID: 16182838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised trialomania? The multicentre liver transplant trials of tacrolimus.
    Starzl TE; Donner A; Eliasziw M; Stitt L; Meier P; Fung JJ; McMichael JP; Todo S
    Lancet; 1995 Nov; 346(8986):1346-50. PubMed ID: 7475777
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus in the prevention of graft rejection: new indication. Helpful alternative to ciclosporin.
    Prescrire Int; 1998 Aug; 7(36):108-9. PubMed ID: 10342948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine: advantages versus disadvantages vis-à-vis tacrolimus.
    Maes BD; Vanrenterghem YF
    Transplant Proc; 2004 Mar; 36(2 Suppl):40S-49S. PubMed ID: 15041305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of immunosuppression in liver transplantation: contribution of cyclosporine.
    Furukawa H; Todo S
    Transplant Proc; 2004 Mar; 36(2 Suppl):274S-284S. PubMed ID: 15041353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
    Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
    Ogino S; Hashikura Y; Katsuyama Y; Ikegami T; Nakazawa Y; Urata K; Terada M; Miyagawa S; Kawasaki S
    Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
    Villamil F; Levy G; Grazi GL; Mies S; Samuel D; Sanjuan F; Rossi M; Lake J; Munn S; Mühlbacher F; Leonardi L; Cillo U
    Transplant Proc; 2006 Nov; 38(9):2964-7. PubMed ID: 17112875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
    Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
    [No Abstract]   [Full Text] [Related]  

  • 18. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA; Gimson AE; Gibbs P; Alexander GJ
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation.
    Hachem RR; Yusen RD; Chakinala MM; Meyers BF; Lynch JP; Aloush AA; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.